Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026
Rhea-AI Summary
Tactile Medical (Nasdaq: TCMD) will release its second quarter fiscal 2026 financial results after the market close on Monday, August 10, 2026. Management will host a conference call and live webcast at 5:00 p.m. Eastern Time the same day to discuss quarterly results.
Positive
- None.
Negative
- None.
News Market Reaction – TCMD
In the Jul 22 session, TCMD declined 2.85%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 20 | Earnings date | Neutral | -2.8% | The scheduled release announcement preceded a negative 24-hour price reaction. |
| Feb 03 | Earnings date | Neutral | -2.1% | The scheduled release announcement preceded a negative 24-hour price reaction. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings-date announcements in the tag-specific history were followed by negative 24-hour reactions of -2.82% and -2.09%.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, July 21, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that second quarter of fiscal year 2026 financial results will be released after the market closes on Monday, August 10, 2026.
Management will host a conference call with a question and answer session at 5:00 p.m. Eastern Time on August 10, 2026, to discuss the results of the quarter. Those who would like to participate may dial 877-407-3088 (201-389-0927 for international callers) and provide access code 13761142. A live webcast of the call will also be provided on the investor relations section of the Company's website at investors.tactilemedical.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13759535. The webcast will be archived at investors.tactilemedical.com.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic inflammatory lung disease by helping them live better and care for themselves. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs, and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com